Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
76,991,404
-
Total 13F shares
-
13,088,070
-
Share change
-
-177,458
-
Total reported value
-
$114,093,428
-
Price per share
-
$8.74
-
Number of holders
-
48
-
Value change
-
-$1,666,906
-
Number of buys
-
22
-
Number of sells
-
16
Institutional Holders of Clearside Biomedical, Inc. - Common Stock, $0.001 par value (CLSD) as of Q3 2017
As of 30 Sep 2017 Clearside Biomedical, Inc. - Common Stock, $0.001 par value (CLSD) had 48 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 13,088,070 shares of stock of the company.
Largest 10 holders included WELLINGTON MANAGEMENT GROUP LLP, Cormorant Asset Management, LLC, BlackRock Inc., FMR LLC, Rock Springs Capital Management LP, Hillhouse Capital Management, Ltd., VANGUARD GROUP INC, PERCEPTIVE ADVISORS LLC, FIRST MANHATTAN CO, and SPHERA FUNDS MANAGEMENT LTD..
This table shows 48 institutional shareholders of the security as of 30 Sep 2017.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.